BioRestorative Therapies Receives a Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its Obesity Program
–Notice of allowance will be the fourth U.S. patent granted under Company’s ThermoStem® program targeting obesity and metabolic disorders, including type 2 diabetes–
Related news for (BRTX)
- BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025
- BioRestorative Therapies Reports 2024 Financial Results and Provides Business Update
- Today’s Top Performers: MoBot’s Market Review 02/25/25 07:00 PM
- MoBot’s Stock Market Highlights – 02/25/25 06:00 PM
- MoBot’s Stock Market Highlights – 02/20/25 08:00 AM